Zhejiang Qianjiang Biochemical Co., Ltd
600796.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.24 | 0.00 | 0.54 | 2.49 |
| FCF Yield | -8.97% | 2.27% | 0.74% | -4.07% |
| EV / EBITDA | 12.57 | 11.67 | 9.90 | 12.59 |
| Quality | ||||
| ROIC | 1.88% | 3.12% | 4.53% | 4.07% |
| Gross Margin | 22.99% | 23.53% | 21.96% | 23.00% |
| Cash Conversion Ratio | 2.98 | 1.92 | 2.11 | 2.27 |
| Growth | ||||
| Revenue 3-Year CAGR | -4.16% | 0.06% | 67.22% | 74.79% |
| Free Cash Flow Growth | -478.90% | 242.48% | 117.22% | -810.34% |
| Safety | ||||
| Net Debt / EBITDA | 2.37 | 2.14 | 1.81 | 2.17 |
| Interest Coverage | 1.91 | 2.59 | 3.19 | 2.98 |
| Efficiency | ||||
| Inventory Turnover | 7.05 | 7.94 | 12.09 | 14.00 |
| Cash Conversion Cycle | 87.49 | 84.92 | 118.85 | 156.10 |